90461300 - UNTIL CANCER IS CURED

Information

  • Trademark
  • 90461300
  • Serial Number
    90461300
  • Filing Date
    January 12, 2021
    3 years ago
  • Transaction Date
    August 30, 2024
    3 months ago
  • Status Date
    August 29, 2024
    3 months ago
  • Published for Opposition Date
    January 11, 2022
    2 years ago
  • Location Date
    March 08, 2022
    2 years ago
  • Status Code
    734
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CAYSIDO, REBECCA TOLEN
  • Attorney Docket Number
    86951.00900
    Attorney Name
    Richard Y. Kim
    Law Office Assigned Location Code
    N50
  • Owners
Mark Drawing Code
4
Mark Identification
UNTIL CANCER IS CURED
Case File Statements
  • GS0391: Providing transportation services of patient tumor samples and biomedical services and methods, namely, the storage of the patient tumor samples for medical use of the patient tumor samples for tissue digestion and cell isolation and expansion, amplification, stimulation and cell growth, and human cells for medical use and storage, and cell population expansion and stimulation, and solid tumor tissue digestion and white blood cell and lymphocyte isolation and white blood cell and lymphocyte storage and white blood cell and lymphocyte expansion and amplification and white blood cell and lymphocyte growth and stimulation; providing medical transport services and biomedical services and methods, namely, the storage of human cells for medical use for treating patients having a tumor and solid tumor
  • GS0051: Cells for medical and clinical use; cell growth media for growing cells for medical and clinical use and cell growth stimulatory factors being synthetic cholesterol mainly for use in growing cell cultures; white blood cell and lymphocyte growth media for growing cells for medical and clinical use and stimulatory factors in the nature of culture media for cultivating human cells; white blood cells and lymphocytes for medical and clinical use; medicaments to help assist with the regeneration of ligament and tendon fibers and cell therapies and treatments containing cells, white blood cells and lymphocytes for medical and clinical use; medical reagents for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; medical reagents for solid tumor tissue digestion, white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation
  • GS0011: Cells for scientific and research use; cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation
  • GS0441: Providing a website featuring information in the field of the diagnosis and treatment of cancer; providing medical services for tissue digestion, cell isolation, cell population expansion and amplification, cell growth and stimulation, solid tumor tissue digestion, white blood cell and lymphocyte isolation, white blood cell and lymphocyte storage, white blood cell and lymphocyte expansion and amplification, and white blood cell and lymphocyte growth and stimulation; providing medical services for treating patients with tumors
  • GS0101: Medical specimen apparatus in the nature of needles, tubing, glass slides, cups, and bags for collection of solid biological tissue samples and specimens, and for collection of solid biological tumor tissue samples, and isolation of cells therefrom and isolation and storage of cells therefrom, and isolation of white blood cells and lymphocytes therefrom, and isolation and storage of white blood cells therefrom
  • GS0421: Medical and scientific research and development in the fields of tissue digestion, tumor tissue digestion, and cell isolation, storage, expansion and amplification, white blood cell and lymphocyte isolation, storage, expansion and amplification, reagents for cell population expansion or amplification, reagents for expansion and amplification of white blood cells and lymphocytes, cell growth and stimulatory factors, white blood cell and lymphocyte growth and stimulatory factors, tumors, white blood cells, lymphocytes, and medical apparatus for collection of solid biological tissue samples and specimens, and for collection of solid biological tumor tissue samples, and isolation of cells therefrom and isolation and storage of cells therefrom, and isolation of white blood cells and lymphocytes therefrom, and isolation and storage of white blood cells therefrom
Case File Event Statements
  • 1/15/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 11/8/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/12/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/6/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/6/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/6/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/6/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/8/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/8/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/6/2021 - 2 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/6/2021 - 2 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 12/6/2021 - 2 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 12/7/2021 - 2 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/7/2021 - 2 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/7/2021 - 2 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/7/2021 - 2 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/7/2021 - 2 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/22/2021 - 2 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/11/2022 - 2 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/11/2022 - 2 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/23/2022 - 2 years ago
    21 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/23/2022 - 2 years ago
    22 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/23/2022 - 2 years ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/8/2022 - 2 years ago
    24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/28/2022 - 2 years ago
    25 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/28/2022 - 2 years ago
    26 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/28/2022 - 2 years ago
    27 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/1/2022 - 2 years ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 9/1/2022 - 2 years ago
    29 - SOU EXTENSION 1 FILED Type: EXT1
  • 9/1/2022 - 2 years ago
    30 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 9/3/2022 - 2 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/13/2023 - a year ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/13/2023 - a year ago
    33 - SOU EXTENSION 2 FILED Type: EXT2
  • 2/13/2023 - a year ago
    34 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 2/15/2023 - a year ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/19/2023 - a year ago
    40 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/19/2023 - a year ago
    36 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/19/2023 - a year ago
    37 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/19/2023 - a year ago
    38 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/19/2023 - a year ago
    39 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/1/2023 - a year ago
    41 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 9/1/2023 - a year ago
    42 - SOU EXTENSION 3 FILED Type: EXT3
  • 9/1/2023 - a year ago
    43 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 2/28/2024 - 9 months ago
    46 - SOU EXTENSION 4 FILED Type: EXT4
  • 2/29/2024 - 9 months ago
    48 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/29/2024 - 3 months ago
    49 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/29/2024 - 3 months ago
    52 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/29/2024 - 3 months ago
    51 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 8/29/2024 - 3 months ago
    50 - SOU EXTENSION 5 FILED Type: EXT5
  • 9/5/2023 - a year ago
    44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/28/2024 - 9 months ago
    47 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 2/28/2024 - 9 months ago
    45 - SOU TEAS EXTENSION RECEIVED Type: EEXT